GSK agrees US drug price cuts and supply chain deal
GSK strikes a voluntary agreement with the US government to lower prescription medicine costs by up to 66% and bolster American drug supply chains. Read the full details.
Category : Search result: GSK
GSK CEO warns UK drug pricing reforms threaten life sciences
Emma Walmsley warns Britain's life sciences industry faces 'existential threat' from proposed drug pricing reforms that could drive investment and research overseas.
Page 1 of 1